🔒 Lilly's Weight-Loss Pill Approved, Sparking Competition with Novo Nordisk
The FDA approved Foundayo (orforglipron) tablets under NDA 220934 for adults with obesity or overweight with weight-related comorbidities, b…
High impact 15 min
Drug profile · INN
glp-
glp- is an FDA-listed pharmaceutical active ingredient.
NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — glp-
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.70
Quick answer
glp- is an FDA-listed pharmaceutical active ingredient.
Key facts
INN glp-
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Related research
🔒 
🔒 Ensuring Compatibility for GLP-1-based Drugs
The global GLP-1 receptor agonist market reached approximately $66.4 billion in 2025 and is projected to exceed $185 billion by 2033, driven…
High impact 5 min
Frequently asked questions
What is glp-?
glp- is an FDA-listed pharmaceutical active ingredient.